Skip to main content

Table 2 Network meta-analysis (Consistency model)

From: The conservative management for improving Visual Analog Scale (VAS) pain scoring in greater trochanteric pain syndrome: a Bayesian analysis

CSI-B

-0.89 (-3.12, 1.25)

-1.72 (-4.59, 1.09)

1.44 (-1.60, 4.43)

-6.08 (-8.47, -3.38)

-0.59 (-3.16, 1.91)

0.89 (-1.25, 3.12)

CSI-U

-0.87 (-2.63, 0.98)

2.30 (0.25, 4.33)

-5.21 (-6.24, -3.64)

0.30 (-0.98, 1.56)

1.72 (-1.09, 4.59)

0.87 (-0.98, 2.63)

ESWT

3.17 (2.15, 4.13)

-4.34 (-6.33, -1.92)

1.18 (-1.09, 3.30)

-1.44 (-4.43, 1.60)

-2.30 (-4.33, -0.25)

-3.17 (-4.13, -2.15)

EX

-7.50 (-9.70, -4.85)

-2.00 (-4.45, 0.44)

6.08 (3.38, 8.47)

5.21 (3.64, 6.24)

4.34 (1.92, 6.33)

7.50 (4.85, 9.70)

PRP-U

5.52 (3.45, 7.06)

0.59 (-1.91, 3.16)

-0.30 (-1.56, 0.98)

-1.18 (-3.30, 1.09)

2.00 (-0.44, 4.45)

-5.52 (-7.06, -3.45)

UC

  1. PRP-U ultrasound-guided platelet-rich plasma application, CSI-U ultrasound-guided corticosteroids injection, ESWT extracorporeal shockwave treatment, EX exercise, CSI-B corticosteroids injection under landmark, UC usual care